NCT04566393 2026-01-28
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
xCures
Available
Clinical Trials
9 trialsNCT05683548 2025-02-17
RCAP
Replicor Inc.
No longer available
NCT06751524 2024-12-30
Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval
Agenus Inc.
Available
NCT00906984 2024-01-08
TheraSphere
University of California, Irvine
Approved for marketing
NCT02960620 2022-09-28
Therasphere for Unresectable Primary or Secondary Liver Neoplasia
H. Lee Moffitt Cancer Center and Research Institute
No longer available
NCT02436044 2019-08-20
HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC
Sun Yat-sen University
Approved for marketing
NCT00701168 2017-08-23
Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer
Leo W. Jenkins Cancer Center
No longer available
NCT00589030 2017-02-15
Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
City of Hope Medical Center
No longer available
NCT02082691 2014-03-10
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma
The University of Texas Health Science Center at San Antonio
No longer available